[A case of asymptomatic immune checkpoint inhibitor associated myocarditis and myositis].

Wang, F; Gong, X L; Geng, H Y; Cheng, Y; Chen, X N

Wang, F; Gong, X L; Geng, H Y; Cheng, Y; Chen, X N.

Afiliação

Wang F; Department of Medical Oncology, Qinhuai Medical Area, General Hospital of Eastern Theater Command of the Chinese People's Liberation Army, Nanjing 210002, China.
Gong XL; Department of Medical Oncology, Qinhuai Medical Area, General Hospital of Eastern Theater Command of the Chinese People's Liberation Army, Nanjing 210002, China.
Geng HY; Department of Medical Oncology, Qinhuai Medical Area, General Hospital of Eastern Theater Command of the Chinese People's Liberation Army, Nanjing 210002, China.
Cheng Y; Department of Medical Oncology, Qinhuai Medical Area, General Hospital of Eastern Theater Command of the Chinese People's Liberation Army, Nanjing 210002, China.
Chen XN; Department of Medical Oncology, Qinhuai Medical Area, General Hospital of Eastern Theater Command of the Chinese People's Liberation Army, Nanjing 210002, China.

Zhonghua Xin Xue Guan Bing Za Zhi ; 50(11): 1103-1105, 2022 Nov 24.

Article em Zh | MEDLINE | ID: mdl-36418279

Assuntos

Antineoplásicos Imunológicos; Miocardite; Miosite; Humanos; Inibidores de Checkpoint Imunológico; Miosite/induzido quimicamente

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Miocardite / Miosite Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: Zh Revista: Zhonghua Xin Xue Guan Bing Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google